Funding Alert Vol. 30 No. 7 Alert # 3 - July 16, 2019

Texas Department of State Health Services icon Funding Information Center icon Toll free: 1-888-963-7111 ext. 7684 icon Austin phone: (512) 776-7684 icon Fax: (512) 776-7683


The Texas Department of State Health Services Funding Alert is published weekly.  If you wish to subscribe to the Funding Information Center Funding Alert and other services, please call (512) 776-7684 or fill out our online subscription form which can be found at: https://dshs.texas.gov/fic/subscribe.aspx.  Information in the Funding Alert is not copyrighted and may be reproduced. The Texas Department of State Health Services Funding Information Center would appreciate credit for the material used and a copy of the reprint. For information on viewing Adobe Acrobat .pdf and other files, see file viewing information.

Disclaimer: External links to other sites are intended to be informational and do not have the endorsement of the Department of State Health Services. These sites may also not be accessible to persons with disabilities. External e-mail links are provided to you as a courtesy. Please be advised that you are not e-mailing the Texas Department of State Health Services (DSHS) and DSHS policies do not apply should you choose to correspond.


Funding News and Grant Tips

International Humanitarian Aid Totaled Nearly $29 Billion in 2018
International humanitarian assistance totaled a record $28.9 billion in 2018, an increase of 30 percent since 2014, but up just one percent on a year-over-year basis, a study by Development Initiatives finds.
The report, Key Trends in Global Humanitarian Assistance 2019, estimated that total contributions from major donor governments and EU institutions increased in 2018 to $22.6 billion, up from $21.9 billion in 2017. But after four consecutive years of growth, funding from private sources declined to $6.3 billion, from $6.6 billion in 2017.
According to the report, the growth in government assistance can be attributed to significant increases in the amount contributed by the United Arab Emirates (up $1.7 billion, to $2 billion) and Saudi Arabia (up $806 million, to $1.3 billion), offsetting cuts by the three largest government donors — the United States, Germany, and the United Kingdom. The jump in contributions from Middle Eastern and Northern African governments is a reflection, in part, of the concentration of humanitarian assistance flowing to the region, including responses to crises in Syria, Yemen, and South Sudan, which together accounted for 30 percent of country-allocable international humanitarian assistance. In 2017, the top ten recipient countries received 64 percent of all country-allocable humanitarian assistance, up from 59 percent the previous year.
Based on data from 27 countries, the analysis also found that over the first years of a protracted crisis, development assistance declines at a rate faster than the rate at which humanitarian assistance increases. In the fifth year of a crisis, humanitarian assistance to such countries was some $2.9 billion higher than it was in the first year of the crisis, while non-humanitarian development assistance declined some $3.8 billion in the aggregate. The report also found that aid in the form of loans to countries experiencing protracted crises increased 394 percent between 2012 and 2017, while loans to other developing countries was up only 40 percent.
From The Foundation Center's Philanthropy News Digest News email, 7/2/19icon

Foundation Leaders Call for Engaging Residents in Opportunity Zones
The Presidents' Council on Impact Investing, which includes 20 foundation leaders, is calling for greater involvement of local residents in the deployment of investments in Opportunity Zones.
Established by the Tax Cuts and Jobs Act of 2017, Opportunity Zones are an economic development tool created with the aim of incentivizing the investment of private capital to address unmet needs in low-income communities; in return for their investment capital, private investors receive various tax benefits. In a letter, the foundation presidents warn that absent a guarantee that capital will flow to the neighborhoods or projects most likely to benefit those who work and live there, many Opportunity Zones will lose out, even as those in gentrifying parts of New York City and Washington, D.C., continue to draw the lion's share of development capital while leaving longtime residents vulnerable to displacement.
"We know that there is tremendous potential if we invest in the human and social capital that already exists inside these communities," the letter states. "And we also know that success will require clear opportunities for community engagement to ensure local context and priorities are front-and-center in every Opportunity Zone. Indeed, success hinges on the extent to which Opportunity Zones enable current residents to engage and equitably participate in defining how new investments ultimately reshape and strengthen the physical, social, and economic fabric of their communities."
To ensure that Opportunity Zone residents are equitably involved in the effort, the foundation presidents call on policy makers at the federal, state, and local levels to leverage incentives and regulations in order to protect the voices and advance the priorities of residents; on investors and fund managers to promote authentic community engagement in order to determine investment priorities, respond to residents' needs, and shape a shared vision for equitable development; and on impact investors and grantmakers to stand committed to collectively championing residents' voices and holding market actors accountable for the outcomes of their investments.
Convened by the U.S. Impact Investing Alliance, the council's members include the leaders of the Annie E. Casey, Case, Packard, Ford, Heron, MacArthur, Kresge, Lumina, McKnight, Nathan Cummings, Open Society, Rockefeller, Sorenson Impact, Surdna, and W.K. Kellogg foundations; the Meyer Memorial Trust; and the Rockefeller Brothers Fund.
From The Foundation Center's Philanthropy News Digest News email, 7/2/19icon


Public Funding Opportunities

Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed) (Reissue of PAR-15-360): PAR-18-923 
SOURCE: National Institute of Allergy and Infectious Diseases (NIAID) 
APPLICATION DEADLINE: Application: 1/14/20 and 1/14/21 by 5 pm local time of applicant organization.
$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
ELIGIBILITY: * Public/state/private controlled institutions of higher education.
* Hispanic-serving institutions.
* Historically Black Colleges and Universities (HBCUs).
* Tribally Controlled Colleges and Universities (TCCUs).
* Alaska native and native Hawaiian serving institutions.
* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
* Small businesses.
* For-profit organizations (other than small businesses).
* State governments.
* County governments.
* City or township governments.
* Special district governments.
* Indian/Native American tribal governments (federally recognized and other than federally recognized).
* Eligible agencies of the federal government.
* U.S. territories or possessions.
* Independent school districts.
* Public housing authorities/Indian housing authorities.
* Native American tribal organizations (other than federally recognized tribal governments).
* Faith-based or community-based organizations.
* Regional organizations.
* Non-domestic (non-U.S.) entities (foreign institutions).
PURPOSE: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative studies to identify and understand the immunological responses that mediate protection from Mycobacterium tuberculosis (Mtb) infection or following vaccination with Bacillus Calmette-Guérin (BCG) or investigational vaccines. Studies may focus on any stage of mycobacterial infection and may include HIV-infected or uninfected individuals. Development of novel functional assays to assess host response and inclusion of immune profiling and systems biology approaches are encouraged.
This FOA seeks to stimulate innovative research in deciphering immune mechanisms in humans required for protection from Mtb infection or tuberculosis (TB) disease, or induced by TB vaccines, that go beyond what have traditionally been investigated in TB.  
CFDA: 93.855
CONTACT: Please see URL for multiple contacts. For more information see https://grants.nih.gov/grants/guide/pa-files/PAR-18-923.html
From CDC National Prevention Information Network's (NPIN) HIV/Hepatitis/STD/TB Funding Information email, 7/3/19icon 
Subject(s) HIV/AIDS research, medical research

Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed) (Reissue of PAR-16-254): PAR-19-307 
SOURCE: National Institute of Allergy and Infectious Diseases (NIAID) 
APPLICATION DEADLINE: Application: 1/14/20, 1/14/21, and 1/14/22 by 5 pm local time of applicant organization.
$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
ELIGIBILITY: * Public/state/private controlled institutions of higher education.
* Hispanic-serving institutions.
* Historically Black Colleges and Universities (HBCUs).
* Tribally Controlled Colleges and Universities (TCCUs).
* Alaska native and native Hawaiian serving institutions.
* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
* Small businesses.
* For-profit organizations (other than small businesses).
* State governments.
* County governments.
* City or township governments.
* Special district governments.
* Indian/Native American tribal governments (federally recognized and other than federally recognized).
* Eligible agencies of the federal government.
* U.S. territories or possessions.
* Independent school districts.
* Public housing authorities/Indian housing authorities.
* Native American tribal organizations (other than federally recognized tribal governments).
* Faith-based or community-based organizations.
* Regional organizations.
* Non-domestic (non-U.S.) entities (foreign institutions).
PURPOSE: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative studies to identify and understand the immune responses that mediate protection from Mycobacterium tuberculosis (Mtb) infection or progression to active tuberculosis (TB) disease. Such responses may be operative in mycobacterial infection, or following vaccination with Bacillus Calmette-Guérin (BCG) or investigational TB vaccines. Studies may focus on any stage of mycobacterial infection and may include HIV-infected and/or uninfected individuals. Research supported under this FOA should go beyond descriptive information currently known about Mtb infection, immune responses to TB vaccines, or immune modulation by non-tuberculous mycobacterial (NTM) infection, or by HIV/AIDS. Applications are sought that include characterization of the timing, anatomical location, and contribution to disease outcome, of mucosal and/or systemic immune responses to mycobacterial infection and/or vaccination. This research is expected to advance understanding of immune mechanisms in Mtb infection/vaccination and contribute to the advancement of new TB vaccines, including in populations also infected with HIV.
CFDA: 93.855
CONTACT: Please see URL for multiple contacts. For more information see https://grants.nih.gov/grants/guide/pa-files/PAR-19-307.html
From CDC National Prevention Information Network's (NPIN) HIV/Hepatitis/STD/TB Funding Information email, 7/3/19icon 
Subject(s) HIV/AIDS research, medical research

Notice of Funding Availability (NOFA) for the Fiscal Year (FY) 2019 Continuum of Care Program Competition: FR-6300-N-25
SOURCE: U.S. Department of Housing and Urban Development (HUD)
APPLICATION DEADLINE: 9/30/19.
$ AVAILABLE: $2.254 billion for 8000 awards.
ELIGIBILITY: See URL for complete eligibility requirements.
PURPOSE: The CoC Program (24 CFR part 578) is designed to promote a community-wide commitment to the goal of ending homelessness; to provide funding for efforts by nonprofit providers, States, and local governments to quickly re-house homeless individuals, families, persons fleeing domestic violence, and youth while minimizing the trauma and dislocation caused by homelessness; to promote access to and effective utilization of mainstream programs by homeless; and to optimize self-sufficiency among those experiencing homelessness.
CFDA: 14.267
CONTACT: Please see URL for contact information. For more information see https://www.grants.gov/web/grants/view-opportunity.html?oppId=318022&utm_campaign=fyi_newsletter&utm_medium=email&utm_source=govdelivery
From U.S. Department of Health and Human Services, Office of Minority Health FYI Weekly Health Resources email, 7/10/19icon 
Subject(s) housing/homeless

OJJDP FY 19 Specialized Services and Mentoring for Child and Youth Victims of Sex Trafficking and Sexual Exploitation: OJJDP201914988
SOURCE: Office of Juvenile Justice Delinquency Prevention (OJJDP)
APPLICATION DEADLINE: 7/29/19.
$ AVAILABLE: $4.9 million for 11 awards.
ELIGIBILITY: See URL for complete eligibility requirements.
PURPOSE: The purpose of the program is to support the efforts of organizations to develop or enhance their mentoring capacity, facilitate outreach efforts, and increase the availability of direct services for child and youth victims of commercial sexual exploitation and domestic sex trafficking.
CFDA: 16.726
CONTACT: National Criminal Justice Reference Service Response Center, (800) 851–3420, email: grants@ncjrs.gov. For more information see https://www.grants.gov/web/grants/view-opportunity.html?oppId=316430&utm_campaign=fyi_newsletter&utm_medium=email&utm_source=govdelivery
From U.S. Department of Health and Human Services, Office of Minority Health FYI Weekly Health Resources email, 7/10/19icon 
Subject(s) sexual violence prevention

Regional Partnership Grants to Increase the Well-Being of, and to Improve the Permanency Outcomes for, Children and Families Affected by Opioids and Other Substance Abuse: HHS-2019-ACF-ACYF-CU-1568
SOURCE: U.S. Department of Health and Human Services, Administration for Children and Families 
APPLICATION DEADLINE: 7/31/19.
$ AVAILABLE: $18,550,000 for seven awards.
ELIGIBILITY: See URL for complete eligibility requirements.
PURPOSE: The purpose of this Funding Opportunity Announcement (FOA) is to provide competitive grant funds for Regional Partnership Grants (RPGs) to improve the well-being of, and to improve the permanency outcomes for children and families affected by opioids and other substance abuse. These targeted grants will be awarded to regional partnerships that provide, through interagency collaboration and integration of programs and services, activities and services that are designed to increase the well-being of, improve permanency outcomes for, and enhance the safety of children who are in out-of-home placements or are at risk of entering out-of-home placements as a result of a parent's or caretaker's substance abuse.
CFDA: 93.087
CONTACT: ACF Applications Help Desk, email: app_support@acf.hhs.gov. For more information see https://www.grants.gov/web/grants/view-opportunity.html?oppId=310247&utm_campaign=fyi_newsletter&utm_medium=email&utm_source=govdelivery 
From U.S. Department of Health and Human Services, Office of Minority Health FYI Weekly Health Resources email, 7/3/19icon 
Subject(s) opioid overdose epidemic, substance abuse education/prevention, substance abuse services

Ryan White HIV/AIDS Program Part A HIV Emergency Relief Grant Program: HRSA-20-063 
SOURCE: Health Resources and Services Administration (HRSA)
APPLICATION DEADLINE: 9/30/19.
$ AVAILABLE: $620 million for 52 awards.
ELIGIBILITY: See URL for complete eligibility requirements.
PURPOSE: The purpose of this program is to provide direct financial assistance to an eligible metropolitan area (EMA) or a transitional grant area (TGA) that has been severely affected by the HIV epidemic. Grant funds assist eligible jurisdictions to develop or enhance access to a comprehensive continuum of high quality, community-based care for people with HIV who are low-income through the provision of formula, supplemental, and Minority AIDS Initiative (MAI) funds. RWHAP Part A recipients must provide comprehensive primary health care and support services throughout the entire designated geographic service area. The goal is to provide optimal HIV care and treatment for people with HIV who are low-income, uninsured, and underserved, to improve their health outcomes.
CFDA: 93.914
CONTACT: Steven R. Young, (301) 443-9091, email: SYoung@hrsa.gov. For more information see https://www.grants.gov/web/grants/search-grants.html?keywords=HRSA-20-063
From CDC National Prevention Information Network's (NPIN) HIV/Hepatitis/STD/TB Funding Information email, 7/3/19icon 
Subject(s) HIV/AIDS services, minority health

Teaching Health Center Graduate Medical Education (THCGME) Program: HRSA-20-011
SOURCE: Health Resources and Services Administration (HRSA)
APPLICATION DEADLINE: 8/30/19.
$ AVAILABLE: $48 million for 61 awards.
ELIGIBILITY: See URL for complete eligibility requirements.
PURPOSE: The purpose of the THCGME Program is to support the training of residents in new or expanded primary care residency training programs in community-based ambulatory patient care centers. 
CFDA: 93.530
CONTACT: Kristin Gordon, (301) 443-0337, email: Kgordon@hrsa.gov. For more information see https://www.grants.gov/web/grants/view-opportunity.html?oppId=315886&utm_campaign=fyi_newsletter&utm_medium=email&utm_source=govdelivery
From U.S. Department of Health and Human Services, Office of Minority Health FYI Weekly Health Resources email, 7/3/19icon 
Subject(s) health education

Tuberculosis Elimination and Laboratory Cooperative Agreement: CDC-RFA-PS20-2001
SOURCE: Centers for Disease Control and Prevention (CDC)
APPLICATION DEADLINE: 9/5/19.
$ AVAILABLE: Not listed.
ELIGIBILITY: Competition is limited to 61 project areas, including 50 state public health agencies or their bona fide agents; the cities of Los Angeles, CA; San Francisco, CA; San Diego, CA; Houston, TX; Chicago, IL; New York, NY; Philadelphia, PA; Baltimore, MD; Washington, D.C.; and the territorial governments of Puerto Rico and U.S. Virgin Islands. Eligible applicants with laboratories can apply for laboratory funding.
PURPOSE: Meeting the U.S. TB elimination goal will require an added focus on testing and treating high-risk persons with latent TB infection (LTBI) to prevent them from developing active TB disease. CDC estimates that up to 13.0 million people in the United States have LTBI and over 80 percent of U.S. TB cases result from longstanding, untreated LTBI. This NOFO supports the continued focus on identifying and curing persons with TB disease, but also includes the addition of a targeted testing and treatment strategy for LTBI. TB disproportionately affects certain populations, including those who are non-U.S.-born, with HIV infection or diabetes, experiencing homelessness, who are incarcerated, and who use illicit substances. The TB incidence rate among non-U.S.-born persons in 2017 was approximately 15 times greater compared to U.S.-born persons, and the percentage of TB cases occurring in non-U.S.-born persons continues to increase, reaching 70.1 percent in 2017. Achieving TB elimination in the United States will require focusing on persons in these high-risk groups – an approach that is reinforced by this NOFO. CDC is continuing a 30-year strategy of funding TB programs through cooperative agreements (CoAgs). The primary responsibility for developing and implementing TB P&C and laboratory activities rests with state and local health departments, and this funding is intended to complement those efforts. The intent of this funding is not to supplant or reduce state and local investment in TB control activities and responsibilities (e.g., provision of medications, in-patient care, and health department facilities).
CFDA: 93.116
CONTACT: Glenroy Christie, email: GPC5@cdc.gov. For more information see https://www.grants.gov/web/grants/view-opportunity.html?oppId=316159
From CDC National Prevention Information Network's (NPIN) HIV/Hepatitis/STD/TB Funding Information email, 7/11/19icon 
Subject(s) medical research


Private Funding Opportunities

American Gastroenterological Association Invites Applications for Funderberg Research Award in Gastric Cancer
SOURCE: American Gastroenterological Association (AGA)
APPLICATION DEADLINE: 8/7/19.
$ AVAILABLE: A single two-year grant of up to $100,000. 
ELIGIBILITY: To be eligible, candidates hold an MD, PhD, and/or equivalent degree (e.g., MB, ChB, MBBS, DO), as well as a full-time faculty position at an accredited institution in North America (U.S., Canada, or Mexico). ASA membership is required at the time of application submission. Applicants who are physician-scientists, female, or from racial/ethnic groups underrepresented in biomedical research are strongly encouraged to apply.
PURPOSE: The American Gastroenterological Association is inviting applications for the Robert and Sally Funderburg Research Award in Gastric Cancer.
Through the program, a single two-year grant of up to $100,000 will be awarded to an established investigator in the field of gastric biology in support of basic, translational, or clinical research that enhances the fundamental understanding of gastric cancer pathobiology, with the goal of ultimately preventing or developing a cure.
The AGA has identified the following areas of particular interest: gastric mucosal cell biology; regeneration and regulation of cell growth (not as they relate to peptic ulcer disease or repair); inflammation (including Helicobacter pylori) as pre-cancerous lesions; genetics of gastric carcinoma; oncogenes in gastric epithelial malignancies; epidemiology of gastric cancer; etiology of gastric epithelial malignancies; clinical research in the diagnosis or treatment of gastric carcinoma; and evidence gaps highlighted in AGA’s GI Cancer Surveillance in Gastric Intestinal Metaplasia. Clinical research includes health services research to address the implementation of the guidelines into clinical practice.
CONTACT: Please see URL for contact information. For more information see https://www.gastro.org/research-and-awards/research-awards/apply-for-awards/award/aga-r-robert-and-sally-funderburg-research-award-in-gastric-cancer
From The Foundation Center's Philanthropy News Digest RFP Bulletin email, 7/5/19icon
Subject(s) cancer research

American Hearing and Research Foundation Accepting Applications for Menire’s Disease Research
SOURCE: American Hearing and Research Foundation
APPLICATION DEADLINE: 8/15/19.
$ AVAILABLE: Grants of up to $25,000. 
ELIGIBILITY: To be eligible, applicants must hold an MD, PhD, AuD, or equivalent degree(s) and be associated with a university or hospital in the United States.
PURPOSE: The American Hearing and Research Foundation is accepting applications to its Menire’s Disease Grant program.
Through the program, grants of up to $25,000 will be awarded in support of research on the causes, diagnosis, and/or treatment of Meniere’s disease, with a focus on the hearing or balance functions of the ear. Basic and clinical studies that investigate aspects of the auditory and vestibular systems, including but not limited to genetics, neurotology, anatomy, auditory processing, molecular and cellular biology, therapeutic studies, and investigations of current or experimental devices (i.e., cochlear implants), may be proposed.
CONTACT: Please see URL for contact information. For more information see https://www.american-hearing.org/research-grants/grants-we-offer/
From The Foundation Center's Philanthropy News Digest web site, accessed 7/11/19icon
Subject(s) medical research

Amyloidosis Foundation Invites Applications for Research Projects
SOURCE: Amyloidosis Foundation 
APPLICATION DEADLINE: 9/13/19.
$ AVAILABLE: Grants of up to $50,000. 
ELIGIBILITY: To be eligible, applicants must be within ten years of completion of their postdoctoral studies or a clinical fellowship and must have a mentor to guarantee the research environment will support the applicant’s project.
PURPOSE: The Amyloidosis Foundation is committed to serving patient needs by providing annual grants to junior research scientists whose research targets the challenges in the field of amyloidosis and by investing in innovative research models with the potential to expedite promising therapies for patients.
To that end, the foundation is accepting applications for its Research Grants program. Through the program, grants of up to $50,000 will be awarded to early-career scientists in support of basic biomedical and clinical research on systemic amyloidosis.
CONTACT: Please see URL for contact information. For more information see http://amyloidosis.org/research/#grant-programs
From The Foundation Center's Philanthropy News Digest web site, accessed 7/11/19icon
Subject(s) medical research

Anthem Foundation Invites Applications for Community Health Programs
SOURCE: Anthem Foundation 
APPLICATION DEADLINE: 8/9/19.
$ AVAILABLE: See URL for funding information.
ELIGIBILITY: To be eligible, organizations must be tax exempt under section 501(c)(3) of the Internal Revenue Code and be based in a state where Anthem does business, including Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Missouri, Nevada, New Hampshire, New Jersey, New York, Ohio, Tennessee, Texas, Virginia, Washington, West Virginia, and Wisconsin.
PURPOSE: The Anthem Foundation is accepting applications for its Program Grants.
Through the program, grants will be awarded within the foundation’s service areas in support of community health programs aligned with the foundation’s Healthy Generations program parameters, which include healthy hearts, cancer prevention, healthy maternal practices, healthy diabetes prevention, and active lifestyle. The foundation welcomes traditional and non-traditional problem-solving approaches, including programs that provide services directly to people and those to change systems and transform healthcare.
CONTACT: Please see URL for contact information. For more information see http://www.anthemcorporateresponsibility.com/funding-options
From The Foundation Center's Philanthropy News Digest RFP Bulletin email, 7/5/19icon
Subject(s) community health

Association for Academic Surgery Invites Applications for Joel J. Roslyn Faculty Research Award
SOURCE: Association for Academic Surgery (AAS)
APPLICATION DEADLINE: 8/5/19.
$ AVAILABLE: A single grant of $50,000.
ELIGIBILITY: To be eligible, applicants must be full-time faculty who have not yet attained the rank of associate professor. Applicants must also be an active member of AAS and must have at least one mentor who is an active or senior member of AAS.
PURPOSE: Founded in 1966, the Association for Academic Surgery works to inspire and develop young academic surgeons and is widely recognized as an inclusive surgical organization with more than four thousand members.
In support of this mission, AAS is inviting applications for its Joel J. Roslyn Faculty Research Award. Supported by the Journal of Surgical Research and its publisher, Elsevier Science, the award seeks to provide early-career research support to junior faculty members of AAS.
To that end, a single grant of $50,000 will be awarded in support of proposed research to be conducted by a junior faculty member in any surgical specialty or discipline.
CONTACT: Please see URL for contact information. For more information see https://www.aasurg.org/awards/roslyn-faculty-award/
From The Foundation Center's Philanthropy News Digest web site, accessed 7/11/19icon
Subject(s) medical research

Christopher & Dana Reeve Foundation Assistive Technology Grant Cycle Opens July 15
SOURCE: Christopher & Dana Reeve Foundation
APPLICATION DEADLINE: The new application cycle for the HIIAT grants will be open for two months, with applications due by 9/16/19. The foundation will host an applicant technical assistance webinar on 7/22/19 and announce its funding decisions in the beginning of November for a one-year grant period running from 12/1/19, through 11/30/20.
$ AVAILABLE: One-year grants of up to $75,000.
ELIGIBILITY: Starting with the new grant cycle opening on July 15, previously awarded Quality of Life Grantees are now eligible to apply. However, past grantees must submit proposals for new and innovative projects and not replications of previously awarded projects. They also must be in good standing with the Reeve Foundation, which is defined as having successfully closed out their past grant award, including a timely submitted final report indicating program accomplishments and fully expended grant funds as related to the awarded grant budget.
PURPOSE: Launched in 2015 in partnership with the Administration for Community Living (ACL), the Christopher & Dana Reeve Foundation’s High Impact Innovative Assistive Technology (HIIAT) Grant is a competitive grant cycle that awards a small number of one-year grants of up to $75,000.
Part of the foundation’s overall Quality of Life Grant Program, the grant helps state programs expand their reach in the field of assistive technology through new innovations that impact people living with paralysis in their homes and communities. For the 2019 cycle, the HIIAT grants program recently made changes to its application process.
CONTACT: Please see URL for contact information. For more information see http://www.anthemcorporateresponsibility.com/funding-options
From The Foundation Center's Philanthropy News Digest web site, accessed 7/11/19icon
Subject(s) disabilities

Pardee Foundation Invites Proposals for Cancer Research
SOURCE: Elsa U. Pardee Foundation
APPLICATION DEADLINE: 8/31/19.
$ AVAILABLE: See URL for funding information.
ELIGIBILITY: The Elsa U. Pardee Foundation is inviting applications from investigators working at nonprofit institutions in the U.S. in support of innovative research directed toward identifying new treatments or cures for cancer.
PURPOSE: Elsa Uhinck Pardee was born on a farm south of Cleveland, Ohio, on November 7, 1884, and received her elementary education in a one-room school. Elsa married James T. Pardee in 1914. A college classmate of Herbert H. Dow, Mr. Pardee was a founder and board member of the Dow Chemical Company. Before her death from breast cancer in 1944 at the age of 59, Elsa directed that $1 million in Dow stock be devoted to the “control and cure of cancer.” The Elsa U. Pardee Foundation was formed in memory of Elsa by the family she left behind.
The foundation encourages proposals for a one-year period that allow all the capabilities of a new cancer researcher or new cancer approaches by an established cancer researcher to be established. The foundation anticipates that this early-stage funding may lead to subsequent and expanded support from a government agency or other source. The relevance of the project to cancer detection, treatment, or cure should be clearly identified.
CONTACT: Please see URL for contact information. For more information see https://pardeefoundation.org/how-to-apply/
From The Foundation Center's Philanthropy News Digest web site, accessed 7/11/19icon
Subject(s) cancer research

Robert Wood Johnson Foundation Invites Applications for Proposals Building Capacity to Reduce Tobacco Inequities
SOURCE: Robert Wood Johnson Foundation (RWJF)
APPLICATION DEADLINE: Brief proposals are due 8/29/19. Upon review, selected applicants will be invited to submit a full proposal by 11/11/19.
$ AVAILABLE: Grants of up to $1.5 million. 
ELIGIBILITY: To be eligible, applicants must either be a public entity or a tax-exempt nonprofit organization as defined by section 501(c)(3) of the Internal Revenue Code and be based in the United States or one of its territories.
PURPOSE: The Robert Wood Johnson Foundation has issued a call for proposals for its Building Capacity to Reduce Tobacco Inequities in the South and Midwest funding opportunity.
Tobacco use remains the number-one cause of preventable deaths in the United States and disproportionately harms people of color, people with lower incomes, and people living in rural areas — especially in the South and Midwest. 
To address the problem, RWJF seeks to support and engage black community members, persons of lower socioeconomic status, and rural residents in the South and Midwest in order to increase their ability to advocate for stronger, locally, or regionally driven tobacco-control and prevention policies and practices.
Grants of up to $1.5 million will fund up to half a dozen two-year projects aimed at addressing tobacco-related inequities. The funding is intended to support organizations working with and representing black residents, lower-income residents, and rural residents in the following thirteen states: Alabama, Arkansas, Indiana, Kentucky, Louisiana, Michigan, Mississippi, Missouri, Ohio, Oklahoma, South Carolina, Tennessee, and West Virginia. Proposals can focus on a single state, on multiple states, or the entire region. Although projects do not have to focus on rural areas, the foundation anticipates that it will fund at least one project with a significant rural component. Proposals that do not focus on all thirteen states should make clear why they are choosing to focus on a particular state or states and how they expect their work will spread to other states over the next five years.
A history of working on commercial tobacco control and prevention is not required; however, it is expect that funded organizations will work closely with organizations that focus on commercial tobacco control and prevention. Applications are encouraged that include regranting to support community-based organizations or efforts. 
The foundation will be hosting an informational webinar on 7/17/19 at 2 pm ET.
CONTACT: Matthew Pierce, email: mpierce@rwjf.org. For more information see https://www.rwjf.org/en/library/funding-opportunities/2019/building-capacity-to-reduce-tobacco-inequities-in-the-south-and-midwest.html
From The Foundation Center's Philanthropy News Digest web site, accessed 7/11/19icon
Subject(s) prevention, smoking/tobacco

W.M. Keck Foundation Accepting Applications for Pioneering Research
SOURCE: W.M. Keck Foundation 
APPLICATION DEADLINE: Applicants are strongly encouraged to contact foundation staff during the pre-application counseling period, which takes place between 7/1/19 and 8/15/19 leading up to a 11/1/19 Phase I submission deadline. Potential applicants are encouraged to submit their ideas for grants in the form of single-page concept papers during the pre-application counseling period.
$ AVAILABLE: Grants ranging between $500,000 and $5 million (though typically $2 million or less) will be awarded for periods of from one to five years.
ELIGIBILITY: To be eligible, applicants must be tax exempt under section 501(c)(3) of the Internal Revenue Code and be designated as a public charity (not a private foundation) as defined by Section 509(a)(1) or 509(a)(2) or 170(b)(1)(A)(I-VI); or be an exempt operating foundation as defined by Section 4940(d)(2). If the institution is located in California, the organization must also be exempt from California State Franchise or Income Tax under Section 23701(d) of the Revenue and Taxation Code.
PURPOSE: The W.M. Keck Foundation was established in 1954 by William Myron Keck, founder of the Superior Oil Company, with the goal of generating far-reaching benefits for humanity.
The foundation currently is accepting applications for its Research Program, which supports pioneering discoveries in science, engineering, and medical research. Grants will be awarded to research universities, medical colleges, and major private independent scientific and medical research institutions in support of projects that are focused on important and emerging areas of research; have the potential to develop breakthrough technologies, instrumentation, or methodologies; are innovative, distinctive and interdisciplinary; demonstrate a high level of risk due to unconventional approaches or by challenging the prevailing paradigm; and have the potential for transformative impact, such as the founding of a new field of research, the enabling of observations not previously possible, or the altered perception of a previously intractable problem.
The program seeks to fund high-risk/high-impact work by researchers with the potential to lay the groundwork for new paradigms, technologies, and discoveries that will save lives, provide innovative solutions, and add to our collective understanding of the world.
CONTACT: Please see URL for contact information. For more information see http://www.wmkeck.org/grant-programs/research
From The Foundation Center's Philanthropy News Digest web site, accessed 7/11/19icon
Subject(s) medical research


Events

Webinar - Implementing Federal Purchase Limits for Federal Assistance
SPONSOR: Thompson Grants
WHEN: July 31, noon to 1:30 pm.
WHERE: Webinar.
DESCRIPTION: In this webinar, grants management consultant Sandra Swab breaks down how the federal purchase limits affect procurement—and how the changes may affect other Uniform Grant Guidance components and grant administration.
How to manage the full impact. The changes to the micro purchase limit and SAT are in effect now. You’ll get expert guidance on how to implement the requirements and manage the changes they create throughout your organization. Plus, you’ll have the chance to ask your own questions during the Q&A portion of the webinar.
COST: $249 live. $249 on demand. $349 live and on demand. For more information and registration go to http://grants.thompson.com/Implementing-Federal-Purchase-Limits-for-Federal-Assistance-2019?_zs=hXbRL1&_zl=eh5C5
CONTACT: Thompson Grants, (800) 677-3789, email: service@thompson.com.
From Thompson Grants email, 7/11/19icon

Webinar - Post-Award Compliance: When Legal and Grants Issues Intersect
SPONSOR: Thompson Grants
WHEN: July 23, noon to 1:30 pm.
WHERE: Webinar.
DESCRIPTION: 1. Do you know where and how legal and management issues intersect throughout the entire grant lifecycle?
2. Do you manage funding from a programmatic and financial and legal perspective?
3. Do you know whether your internal controls are strong enough to protect current—and future—federal funding?
Under the uniform guidance, there’s no room for guesswork. Now, let leading grants experts show you how to clear any roadblocks before they affect your success.
Rachel Werner has garnered more than $32 million in grants and contracts and she has managed over $2 billion in grant funding. Alexandra Rosenblatt helps federal grantees with best practices and represents them in OIG investigations, agency appeals and litigation. In this webinar, they share expert guidance for staying compliant throughout the grant lifecycle.
Protect current and future funding. From internal controls to procurement and audit issues, you will learn how to manage grants from a programmatic, financial and legal perspective to minimize compliance risks. Plus, you will have the chance to ask your own questions during the Q&A portion of the webinar.
COST: $249 live. $249 on demand. $349 live and on demand. For more information and registration go to http://grants.thompson.com/Post-Award-Compliance-2019?_zs=hXbRL1&_zl=C1XB5
CONTACT: Thompson Grants, (800) 677-3789, email: service@thompson.com.
From Thompson Grants email, 7/7/19icon

Webinar - Using Behavioral Economics to Raise More Money 
SPONSOR: The Chronicle of Philanthropy 
WHEN: September 12, 1 to 2 pm.
WHERE: Webinar.
DESCRIPTION: Every fundraiser wants their approach to be appealing and effective. Many may be surprised to learn, however, that hidden factors are also at work. The growing fields of behavioral economics and decision science can inform why and how people give – and help fundraisers identify the easiest possible ways for donors to make a gift. 
In this one-hour session, you'll learn from Bernard Ross, a consultant and award-winning author who helps organizations improve their performance, and Thomas Kurmann, who utilizes behavioral economics and decision science as Director of Development at Doctors Without Borders. They’ll provide an overview of behavioral economics research, offer tips for applying these techniques to fundraising, and share real-world examples of tactics that worked. 
COST: $79 before September 5. $99 after September 5. For more information and registration go to https://www.philanthropy.com/webinars/detail/1202?cid=WEBINARS1202E1
CONTACT: The Chronicle of Philanthropy, email: events@philanthropy.com
From The Chronicle of Philanthropy email, 6/28/19icon


returnReturn to Alert

Last updated July 15, 2019